NCT03225950

Brief Summary

This study evaluates the interaction between host immune cells and bacteria associated with periodontitis. It comprises biological material from donors with and without periodontal disease. Specifically, we collect a spit and blood sample to conduct in vitro stimulations and measurements of selected parameters related to periodontitis to clarify obscure areas in the immunologic pathogenesis of this disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2017

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 19, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 21, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 12, 2018

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 23, 2020

Completed
Last Updated

March 24, 2020

Status Verified

October 1, 2018

Enrollment Period

1.7 years

First QC Date

July 19, 2017

Last Update Submit

March 23, 2020

Conditions

Keywords

Periodontal diseasePeriodontitisAggressive periodontitisDysbiosisInflammationRegulationCytokinesBacteriaPorphyromonas gingivalisSalivaAnti-CCPPeptidyl arginine deiminasesSingle nucleotide polymorphisms

Outcome Measures

Primary Outcomes (4)

  • periodontitis-associated- and control bacterial stimulation of host immune cells.

    Identification and determination of the amount of cytokine-producing immune cells when stimulated with bacteria associated with periodontitis including pro- and antiinflammatory cytokines. Genuses: Porphyromonas, Prevotella, Eikenella, Aggregatibacter, Actinomyces, Lactobacillus, Bifidobacterium, Rothia.

    Aug. 2020

  • Anti-cyclic citrullinated peptides (anti-CCP) antibodies titers.

    Determination of the prevalence of anti-CCP-positive periodontitis patients through measure of anti-CCP antibody titers in serum samples and correlation with the level of antibodies to P. gingivalis, and to the abundancy of the bacterium in saliva.

    Aug. 2020

  • P. gingivalis presence and related antibodies.

    Determination of P. gingivalis presence in saliva and serum samples through RT-qPCR and determination of the level of antibodies towards the bacterium using in-house Luminex-based technology.

    Aug. 2020

  • Single nucleotide polymorphism (SNP) analysis.

    Investigation of the potential association between periodontitis and selected polymorphisms in the PADI genes using multiplex bead-based SNP assays with the Luminex technology.

    Aug. 2020

Secondary Outcomes (2)

  • Cytokine profile in saliva.

    Aug. 2020

  • Presence of other periodontal bacteria.

    Aug. 2020

Study Arms (3)

Chronic periodontitis donors

* Donors are medically healthy. * Slow to moderate attachment loss and bone destruction. * Good correlation between etiological factors and serverity of attachment loss.

Other: In vitro stimulation of blood with periodontitis-associated- and control bacteriaDiagnostic Test: Anti-CCP- and anti-P.g.-antibodies titersGenetic: Analysis of selected single nucleotide polymorphisms (SNPs)Diagnostic Test: periodontitis-associated bacteria presence

Aggressive periodontitis donors

* Donors are medically healthy. * Rapid attachment loss and bone destruction. * Familial aggregation. * No correlation between etiological factors and serverity of attachment loss.

Other: In vitro stimulation of blood with periodontitis-associated- and control bacteriaDiagnostic Test: Anti-CCP- and anti-P.g.-antibodies titersGenetic: Analysis of selected single nucleotide polymorphisms (SNPs)Diagnostic Test: periodontitis-associated bacteria presence

Control donors

* Donors are medically healthy. * No sign of inflammatory conditions.

Other: In vitro stimulation of blood with periodontitis-associated- and control bacteriaDiagnostic Test: Anti-CCP- and anti-P.g.-antibodies titersGenetic: Analysis of selected single nucleotide polymorphisms (SNPs)Diagnostic Test: periodontitis-associated bacteria presence

Interventions

Peripheral mononuclear blood cells are stimulated with periodontitis-associated- and control bacteria to measure the amount of positive cytokine-producing cells.

Aggressive periodontitis donorsChronic periodontitis donorsControl donors

Anitbody titers will be measured in saliva and serum samples.

Aggressive periodontitis donorsChronic periodontitis donorsControl donors

DNA obtained from saliva samples will be used to determine the genotype of the participants for selected SNPs.

Aggressive periodontitis donorsChronic periodontitis donorsControl donors

Determination of the presence of periodontitis-associated bacteria e.i. Porphyromonas gingivalis in saliva and blood samples.

Aggressive periodontitis donorsChronic periodontitis donorsControl donors

Eligibility Criteria

Age19 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

This study includes 170 participants, which are legally competent e.i. above 18 years of age and general decision competent. The participants are divided into three groups: 1) Participants with chronic periodontitis (n=35), 2) participants with aggressive periodontitis (n=35) and 3) healthy participants without periodontal disease (n=100). The participants are recruited from the Department of Odontology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark and assigned to a group in accordance with the periodontal disease classification system in 1999 American Academy of Periodontology.

You may qualify if:

  • years of age.
  • Interproximal attachment loss at minimum 3 teeth besides molars and incisors.
  • Clinical attachment loss at minimum 10 sites identified by bleeding and pus upon probing.
  • Visible radiographic bone loss.
  • Medically healthy donors.
  • years of age.
  • Interproximal attachment loss at minimum 3 teeth besides molars and incisors.
  • Clinical attachment loss at minimum 10 sites identified by bleeding and pus upon probing.
  • Visible radiographic bone loss.
  • Medically healthy donors.
  • No sign of inflammatory conditions or other general systemic diseases.
  • Medically healthy donors.

You may not qualify if:

  • Pregnant and breastfeeding.
  • Antibiotic treatment within 6 months.
  • Suffer from periodontal manifestations caused by systemic diseases e.i. genetic diseases, haematologic anomalies or syndromes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital.

Copenhagen, 2200, Denmark

Location

Section for Periodontology, Microbiology and Community Dentistry, Department of Odontology, Faculty of Health and Medical Sciences, University of Copenhagen

Copenhagen, 2200, Denmark

Location

Related Publications (15)

  • Bartold PM, Van Dyke TE. Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts. Periodontol 2000. 2013 Jun;62(1):203-17. doi: 10.1111/j.1600-0757.2012.00450.x.

    PMID: 23574467BACKGROUND
  • Neely AL, Holford TR, Loe H, Anerud A, Boysen H. The natural history of periodontal disease in man. Risk factors for progression of attachment loss in individuals receiving no oral health care. J Periodontol. 2001 Aug;72(8):1006-15. doi: 10.1902/jop.2001.72.8.1006.

    PMID: 11525431BACKGROUND
  • Eke PI, Dye BA, Wei L, Slade GD, Thornton-Evans GO, Borgnakke WS, Taylor GW, Page RC, Beck JD, Genco RJ. Update on Prevalence of Periodontitis in Adults in the United States: NHANES 2009 to 2012. J Periodontol. 2015 May;86(5):611-22. doi: 10.1902/jop.2015.140520. Epub 2015 Feb 17.

    PMID: 25688694BACKGROUND
  • Armitage GC. Development of a classification system for periodontal diseases and conditions. Northwest Dent. 2000 Nov-Dec;79(6):31-5.

    PMID: 11413609BACKGROUND
  • Haffajee AD, Socransky SS, Patel MR, Song X. Microbial complexes in supragingival plaque. Oral Microbiol Immunol. 2008 Jun;23(3):196-205. doi: 10.1111/j.1399-302X.2007.00411.x.

    PMID: 18402605BACKGROUND
  • Damgaard C, Holmstrup P, Van Dyke TE, Nielsen CH. The complement system and its role in the pathogenesis of periodontitis: current concepts. J Periodontal Res. 2015 Jun;50(3):283-93. doi: 10.1111/jre.12209. Epub 2014 Jul 5.

    PMID: 25040158BACKGROUND
  • Liu YC, Lerner UH, Teng YT. Cytokine responses against periodontal infection: protective and destructive roles. Periodontol 2000. 2010 Feb;52(1):163-206. doi: 10.1111/j.1600-0757.2009.00321.x. No abstract available.

    PMID: 20017801BACKGROUND
  • Kinane DF, Preshaw PM, Loos BG; Working Group 2 of Seventh European Workshop on Periodontology. Host-response: understanding the cellular and molecular mechanisms of host-microbial interactions--consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol. 2011 Mar;38 Suppl 11:44-8. doi: 10.1111/j.1600-051X.2010.01682.x.

    PMID: 21323703BACKGROUND
  • Pussinen PJ, Jousilahti P, Alfthan G, Palosuo T, Asikainen S, Salomaa V. Antibodies to periodontal pathogens are associated with coronary heart disease. Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1250-4. doi: 10.1161/01.ATV.0000072969.71452.87. Epub 2003 Apr 24.

    PMID: 12714435BACKGROUND
  • Pussinen PJ, Nyyssonen K, Alfthan G, Salonen R, Laukkanen JA, Salonen JT. Serum antibody levels to Actinobacillus actinomycetemcomitans predict the risk for coronary heart disease. Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):833-8. doi: 10.1161/01.ATV.0000157982.69663.59. Epub 2005 Feb 3.

    PMID: 15692101BACKGROUND
  • Berglundh T, Donati M. Aspects of adaptive host response in periodontitis. J Clin Periodontol. 2005;32 Suppl 6:87-107. doi: 10.1111/j.1600-051X.2005.00820.x.

    PMID: 16128832BACKGROUND
  • Fillatreau S. Cytokine-producing B cells as regulators of pathogenic and protective immune responses. Ann Rheum Dis. 2013 Apr;72 Suppl 2:ii80-4. doi: 10.1136/annrheumdis-2012-202253. Epub 2012 Dec 19.

    PMID: 23253921BACKGROUND
  • Belstrom D, Paster BJ, Fiehn NE, Bardow A, Holmstrup P. Salivary bacterial fingerprints of established oral disease revealed by the Human Oral Microbe Identification using Next Generation Sequencing (HOMINGS) technique. J Oral Microbiol. 2016 Jan 14;8:30170. doi: 10.3402/jom.v8.30170. eCollection 2016.

    PMID: 26782357BACKGROUND
  • Belstrom D, Holmstrup P, Bardow A, Kokaras A, Fiehn NE, Paster BJ. Comparative analysis of bacterial profiles in unstimulated and stimulated saliva samples. J Oral Microbiol. 2016 Mar 16;8:30112. doi: 10.3402/jom.v8.30112. eCollection 2016.

    PMID: 26987356BACKGROUND
  • Danielsen AK, Damgaard C, Massarenti L, Ostrup P, Riis Hansen P, Holmstrup P, Nielsen CH. B-cell cytokine responses to Porphyromonas gingivalis in patients with periodontitis and healthy controls. J Periodontol. 2023 Aug;94(8):997-1007. doi: 10.1002/JPER.22-0438. Epub 2023 Mar 5.

Biospecimen

Retention: SAMPLES WITH DNA

Saliva, whole blood, peripheral mononuclear blood cells, serum, plasma.

MeSH Terms

Conditions

Periodontal DiseasesPeriodontitisAggressive PeriodontitisImmune System DiseasesPeriodontal PocketInflammationGingivitisDysbiosisArthritis, RheumatoidChronic Periodontitis

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsInfectionsGingival DiseasesArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesChronic DiseaseDisease Attributes

Study Officials

  • Palle Holmstrup, DDS, PhD, Dr Odont

    University of Copenhagen

    STUDY DIRECTOR
  • Claus Henrik Nielsen, PhD, MSc, MD

    Rigshospitalet, Denmark

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

July 19, 2017

First Posted

July 21, 2017

Study Start

February 1, 2017

Primary Completion

October 12, 2018

Study Completion

March 23, 2020

Last Updated

March 24, 2020

Record last verified: 2018-10

Data Sharing

IPD Sharing
Will not share

IPD will not be available to other researchers in accordance with our approved Human Subjects Protection application in Denmark.

Locations